Business Type:Lab/Research institutions
Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Lab/Research institutions
CAS NO.747-36-4
99%(1-100)Gram
1.In No Less five years exporting experience.
2.Lower Price with higher quality
3,Free sample
4,We are sincerely responsible for the "product quality" and "After Service"
Onchem (China) Co.,Ltd is Specialized in APIs, chemical intermediates, herbal extract and pharmaceutical raw materials.
(1) Company Introduction:
Onchem (China) Co.,Ltd is a comprehensive manufacturer and an international distribution of chemicals throughout the
world. Specialized in APIs, chemical intermediates, herbal extract and pharmaceutical raw materials. our products sell
well in Europe, U.S.A., Japan and Korea, Southeast Asia, Taiwan and other country.
(2) Product Detail
Hydroxychloroquine sulfate
CAS NO.747-36-4
M.F:C18H28ClN3O5S
M.W:433.95
Appearance:white crystalline powder
Purity:>99%
Used for APIs
acter :
This product is white white crystalline powder, odourless, taste bitter. Her face in the water, in ethanol, almost insoluble
in chloroform .
Delivery: 3days by EMS,FEDEX,DHL.
Welcome to Onchem (China) Co.,Ltd, and welcome to inquiry me about all our products, we will provice the
competitive price for u. We are sincerely responsible for the "product quality" and "After Service"
(3) Application
Hydroxychloroquine sulfate was synthesized from Surrey Hammer in 1946. Hydroxychloroquine sulfate has antipyretic,
arthritis eliminate rash inhibition, its anti-inflammatory immune suppression immune regulating mechanism in the complex. In
the 1950 s, along with antimalarial drugs in systemic lupus erythematosus (SLE) rheumatoid arthritis (RA) is the
application of the treatment, the curative effect of hydroxychloroquine sulfate used in the treatment of the rheumatic
diseases fsure. Hydroxychloroquine sulfate used in systemic lupus erythematosus (SLE) rheumatoid arthritis (RA) so on
the treatment of rheumatism, safe, effective well tolerated. Since the 1990 s, more than 90% of clinical treatment of
rheumatism choose hydroxychloroquine sulfate.
1, Systemic lupus erythematosus (SLE)
Hydroxychloroquine in the treatment of discoid lupus erythematosus (SLE) the effect of SLE. [3] found applications
such as Liang Lirong hydroxychloroquine sulfateal discoid lupus erythematosus (sle) curative effect good, before treatment
was significantly improved in patients with various signs, mild adverse reactions.
2, Rheumatoid arthritis (RA)
Hydroxychloroquine sulfate in the treatment of RA curative effect, can improve the symptoms of RA, extremely low
incidence of adverse reactions. A study of hydroxychloroquine sulfate long-term treatment of retrospective study [12] to
observe the curative effect of 366 RA patients, according to the results of research fa period of eight years follow-up
hydroxychloroquine sulfate used in short-term treatment is more valuable. Continuous administration treatment adherence
in December to 63%, down to 46%, 24 months of termination of the treatment group the main reason is long-term drug
failure after taking this medicine.
In view of the safety of hydroxychloroquine sulfate long-term treatment, clinical recommendations fnew onset of light
RA patients, fcombination therapy with other slow-acting drug rheumatism. Hydroxychloroquine sulfate with
methotrexate, willow nitrogen sulfanilamide pyridine ringt application of spore, has become a clinical recognized
(4) Factory Picture: